Gossamer Bio Inc (NASDAQ: GOSS) Stock Forecast: Bullish Signals Pointing To $5 In 2024

In the last trading session, 1.21 million shares of the Gossamer Bio Inc (NASDAQ:GOSS) were traded, and its beta was 1.83. Most recently the company’s share price was $0.74, and it changed around $0.0 or -0.73% from the last close, which brings the market valuation of the company to $166.39M. GOSS currently trades at a discount to its 52-week high of $1.88, offering almost -154.05% off that amount. The share price’s 52-week low was $0.45, which indicates that the current value has risen by an impressive 39.19% since then. We note from Gossamer Bio Inc’s average daily trading volume that its 3-month average coming to 1.31 million.

Gossamer Bio Inc (NASDAQ:GOSS) trade information

Instantly GOSS has showed a red trend with a performance of -0.73% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -19.17% year-to-date, but still down -10.14% over the last five days. On the other hand, Gossamer Bio Inc (NASDAQ:GOSS) is -45.36% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $3.75, which translates to bulls needing to increase their stock price by 80.27% from its current value. Analyst projections state that GOSS is forecast to be at a low of $2 and a high of $5.

Gossamer Bio Inc (GOSS) estimates and forecasts

Gossamer Bio Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 36.16 percent over the past six months and at a 36.44% annual growth rate that is well above the industry average of 13.00%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 63.50% in revenue this quarter, and will report an increase of 57.80% in the next quarter.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 11.99%. Gossamer Bio Inc earnings are expected to increase by 35.82% in 2024, but the outlook is positive 5.20% per year for the next five years.